
Opinion|Podcasts|January 29, 2025
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Advertisement
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
3
EV plus pembro approval reframes first conversation in MIBC diagnosis
4
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
5













